A 12-week Study to Compare the Effects of Vildagliptin Versus Glibenclamide on Glycemic Variability After a Sub Maximal Exercise Test in Patients With Type 2 Diabetes Inadequately Controlled With Metformin.
Phase of Trial: Phase IV
Latest Information Update: 01 Sep 2018
At a glance
- Drugs Glibenclamide (Primary) ; Vildagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIABEX-VILDA
- 01 Sep 2018 Status changed from recruiting to completed, according to the results published in the Diabetes Research and Clinical Practice.
- 31 Aug 2018 Biomarkers information updated
- 19 Jun 2013 New trial record